The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...
The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...
The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.
The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (FDA) has cleared its ...
On-site pathology tests for infectious diseases in rural and remote locations can be just as reliable and accurate as tests carried out in a hospital laboratory, a new report shows. On-site pathology ...
Molecular testing in routine surgical pathology is becoming an important component of the workup of many different types of tumors. In fact, in some organ systems, guidelines now suggest that the ...
In a recent study published in Nature Communications, researchers establish AnimalGAN as a reliable alternative for generating synthetic pathology data in an effort to ultimately reduce animal testing ...
The sheer scale of the GuideSafe Entry Testing initiative is staggering. Part of the multi-tool GuideSafe platform — a partnership between UAB and the Alabama Department of Public Health that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback